Epstein-Barr-Virus-Realtime-CE

Duisburg, Germany

Genekam Biotechnology AG is a company specialised on the following fields: pandemic virology, immunology as well as stem cells. It has around 700 different PCR kits for different targets. It covers all influenza strains, which are circulating around the world. It ranges from H1 to H15 and N1 and N9. There are different strains like H1N1, H5N1, H5N6, H5N8, H7N9, H9N2 etc, which have potential to create pandemic outbreaks. Therefore it is very important that there is continuous monitoring of these viruses with good tests. Regretfully during the coronavirus pandemic outbreak, there are many publications, which have shown poor quality approved tests being used, hence this virus is still circulating, hence such mistakes must be avoided to create an effective monitoring system. Other pathogens covered are Mycobacterium tuberculosis, different Herpes viruses, HCV, HIV, HBV, Yellow fever virus, Rift valley virus, Dengue virus etc. Magnetic beads products: Genekam has developed a number of products to be used in the research. It covers a number of areas: isolation of nucleic acid, protein as well as endotoxins, magnetic beads based gene expression. Magnetic beads ELISA test for detection of nucleoprotein of SARS CoV-2 within 30 minutes. Potential therapeutic molecules: Genekam has developed a number of potential therapeutic antibodies against a number of targets like H1N1, Chlamydia, H3N2, H5N1, Coxiella burnetii, EBV and they are being tested whether they can be used. Genekampowermolecule: It is a molecule from natural source and it is highly effective against coronavirus infection. It can be used as preventive and therapeutic molecules. Genekam is conducting studies with molecule and finding that it is highly effective. Stem cell products: Genekam has developed a number of solutions to be used in stem cells e.g. isolation of the stem cells, PCR kits for different bone markers etc.